Invent medic’s TVS approved for CE marking
Invent medic Sweden AB ("invent medic") hereby announces that the company has received the CE marking approval for its medical device, which means that the product is now approved for sale on the European market. The TVS is scheduled to be launched in Sweden after the summer of 2018.
"It is a great feeling that we have received an approved CE marking of our product, TVS. We continue our work in preparation for the market launch planned for after the summer of 2018. I look forward with great confidence to launching the TVS that can be of great help to the large number of women who today feel uncomfortable leaking urine as a result of stress urinary incontinence. ", says Karin Bryder, CEO of Invent Medic.
For more information please contact
Karin Bryder, CEO
Phone: +46 (0)723 811710
This information is information that Invent Medic Sweden AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 9th July 2018.
Invent Medic Sweden AB, Company registration number 556682-1046, has developed a medical device for non-surgical relief of female stress urinary incontinence. The inventors behind the product, Jan Clarén and Lars-Olof Henriksson, have been involved in the development and performance of the surgical method TVT, which is now known as the Golden Standard for surgical treatment of female stress incontinence. The product is based on the same scientific basis and has similar mechanism of action as the surgical method but is based on a non-surgical support and is designed so that the woman can use the product when needed. This product has the potential to satisfy a major medical need and could thus have a significant market value. Invent medic's vision is to offer new and innovative medical devices and treatment methods to women with the goal of improving their health and quality of life. The offer shall include safe, effective and safe products and treatment methods that should be easy to use and which will provide health economic benefits to society. Invent Medic Sweden AB is listed on Aktietorget. Ticker is IMS and the share's ISIN code is SE0007603402. For more information see www.inventmedic.com and www.spotlightstockmarket.com.